Medical Advanced Technology

Medical Advanced Technology under the Research, Development, Test & Evaluation, Army / BA 3: Advanced Technology Development (ATD), aims to mature and demonstrate advanced medical technologies including drugs, vaccines, medical diagnostic devices, and measures for identification and vector control. The program's specific objectives include refining and validating promising medical technologies through extensive testing in compliance with FDA regulations for human medical products and EPA regulations for insect-control products. The program focuses on late stages of technology maturation activities required to conduct safety and effectiveness clinical trials. Additionally, the program coordinates blast research and field rations maturation with the United States Army Combat Capabilities Development Command Soldier Center to improve body armor design and rations for Soldiers.

The program is externally peer-reviewed and fully coordinated with all Services as well as other agencies through the Joint Technology Coordinating Groups of the Armed Services Biomedical Research Evaluation and Management Community of Interest. The cited research is consistent with the Under Secretary of Defense (Research and Engineering) Science and Technology focus areas and the Army Modernization Strategy. The work in this program is performed by the United States Army Medical Research and Development Command (USAMRDC) at Fort Detrick, MD. The program receives increased funding due to revised economic assumptions, including Congressional adds for specific projects such as Neurofibromatosis research, Breast Cancer Stamp Proceeds, Peer-reviewed Neurotoxin Exposure Treatment Parkinson's Research, Burn Care Training Curriculum, Dengue Vaccine Development, Hearing Protection for Communications, Heat Stress on Female Service Members, Optimizing Military Health and Performance, Freeze Dried Platelets, Rapid Vaccine Development, Suicide Prevention with Focus on Rural, Remote, Isolated, and OCONUS Installations, Trauma Immunology Research, Army Battlefield Exercise and Combat-Related Traumatic Brain and Spinal Cord Injury Research. These projects align with Congressional intent as outlined in NDAA 2019 (Section 711) and NDAA 2020 (Section 737).